Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer

被引:25
作者
Park, Yae Won [1 ,2 ,3 ]
An, Chansik [4 ]
Lee, JaeSeong [5 ]
Han, Kyunghwa [1 ,2 ,3 ]
Choi, Dongmin [6 ]
Ahn, Sung Soo [1 ,2 ,3 ]
Kim, Hwiyoung [1 ,2 ,3 ]
Ahn, Sung Jun [7 ]
Chang, Jong Hee [8 ]
Kim, Se Hoon [9 ]
Lee, Seung-Koo [1 ,2 ,3 ]
机构
[1] Yonsei Univ, Coll Med, Dept Radiol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Res Inst Radiol Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Ctr Clin Imaging Data Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
[4] Natl Hlth Insurance Serv Ilsan Hosp, Res & Anal Team, Goyang, South Korea
[5] Yonsei Univ, Dept Mech Engn, Seoul, South Korea
[6] Yonsei Univ, Dept Comp Sci, Seoul, South Korea
[7] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
[8] Yonsei Univ, Dept Neurosurg, Coll Med, Seoul, South Korea
[9] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Epidermal growth factor receptor; Imaging; Diffusion tensor; Machine learning; Magnetic resonance imaging; Radiomics; TUMORS; FEATURES; PROGRESSION; DIAGNOSIS; SURVIVAL; TEXTURE; LESIONS; GENE;
D O I
10.1007/s00234-020-02529-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose To assess whether the radiomic features of diffusion tensor imaging (DTI) and conventional postcontrast T1-weighted (T1C) images can differentiate the epidermal growth factor receptor (EGFR) mutation status in brain metastases from non-small cell lung cancer (NSCLC). Methods A total of 99 brain metastases in 51 patients who underwent surgery or biopsy with underlying NSCLC and known EGFR mutation statuses (57 from EGFR wild type, 42 from EGFR mutant) were allocated to the training (57 lesions in 31 patients) and test (42 lesions in 20 patients) sets. Radiomic features (n= 526) were extracted from preoperative MR images including T1C and DTI. Radiomics classifiers were constructed by combinations of five feature selectors and four machine learning algorithms. The trained classifiers were validated on the test set, and the classifier performance was assessed by determining the area under the curve (AUC). Results EGFR mutation status showed an overall discordance rate of 12% between the primary tumors and corresponding brain metastases. The best performing classifier was a combination of the tree-based feature selection and linear discriminant algorithm and 5 features were selected (1 from ADC, 2 from fractional anisotropy, and 2 from T1C images), resulting in an AUC, accuracy, sensitivity, and specificity of 0.73, 78.6%, 81.3%, and 76.9% in the test set, respectively. Conclusions Radiomics classifiers integrating multiparametric MRI parameters may have potential in differentiating the EGFR mutation status in brain metastases from NSCLC.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 50 条
  • [31] Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patients
    He, Yayi
    Li, Shuai
    Ren, Shengxiang
    Cai, Weijing
    Li, Xuefei
    Zhao, Chao
    Li, Jiayu
    Chen, Xiaoxia
    Gao, Guanghui
    Li, Wei
    Zhou, Fei
    Zhou, Caicun
    LUNG CANCER, 2013, 81 (02) : 162 - 166
  • [32] Effect of epidermal growth factor receptor gene mutation on bevacizumab combined with erlotinib in the treatment of non-small cell lung cancer
    Yuan, Gao
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (11): : 5175 - 5178
  • [33] Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer
    Sun, Jong-Mu
    Rampal, Sanjay
    Lee, Genehee
    Lee, Jeeyun
    Choi, Yoon-La
    Parasuraman, Bhash
    Guallar, Eliseo
    Cho, Juhee
    Shim, Young Mog
    LUNG CANCER, 2013, 80 (02) : 191 - 196
  • [34] Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients
    Choughule, A.
    Noronha, V
    Joshi, A.
    Desai, S.
    Jannbhekar, N.
    Utture, S.
    Thavamanni, A.
    Prabhash, K.
    Dutt, A.
    INDIAN JOURNAL OF CANCER, 2013, 50 (02) : 107 - 111
  • [35] Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer
    Horiike, Atsushi
    Kimura, Hideharu
    Nishio, Kazuto
    Ohyanagi, Fumiyoshi
    Satoh, Yukitoshi
    Okumura, Sakae
    Ishikawa, Yuichi
    Nakagawa, Ken
    Horai, Takeshi
    Nishio, Makoto
    CHEST, 2007, 131 (06) : 1628 - 1634
  • [36] Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
    Lourdes, Laura S.
    Jalal, Shadia I.
    Hanna, Nasser
    ONCOLOGIST, 2015, 20 (09) : 975 - 978
  • [37] Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
    Van Der Steen, Nele
    Giovannetti, Elisa
    Carbone, Daniela
    Leonetti, Alessandro
    Rolfo, Christian D.
    Peters, Godefridus J.
    CANCER DRUG RESISTANCE, 2018, 1 (04) : 230 - 249
  • [38] Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib
    Kanaoka, Kensuke
    Sumikawa, Hiromitsu
    Oyamada, Shunsuke
    Tamiya, Akihiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Nakao, Keiko
    Matsuda, Yoshinobu
    Okishio, Kyoichi
    BMC CANCER, 2023, 23 (01)
  • [39] Brain Metastasis in Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
    Bhatt, Vijaya R.
    Kedia, Shiksha
    Kessinger, Anne
    Ganti, Apar K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3162 - 3164
  • [40] Deep learning radiomics for the prediction of epidermal growth factor receptor mutation status based on MRI in brain metastasis from lung adenocarcinoma patients
    Cao, Pingdong
    Jia, Xiao
    Wang, Xi
    Fan, Liyuan
    Chen, Zheng
    Zhao, Yuanyuan
    Zhu, Jian
    Wen, Qiang
    BMC CANCER, 2025, 25 (01)